Abstract
Guillain Barre Syndrome (GBS) is an autoimmune neuromuscular disease characterized by the acute progressive weakness, with the complication of respiratory distress. It is important to look for appropriate biomarker to predict the outcome of GBS. In this study, we assess three parameters: albumin, sodium and potassium, to know whether there is an association with the outcome of GBS patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
